A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review

Clinical Rheumatology

Volumn 29, Issue 12, 2010, Pages 1455-1459

  Saougou, Ioanna ^a   Papagoras, Charalampos ^a   Markatseli, Theodora E ^a   Voulgari, Paraskevi V ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Antitumor necrosis factor agents; Dactylitis; Hemodialysis; Infliximab; Plaque psoriasis; Psoriatic arthritis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE KIDNEY FAILURE; ADULT; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CHRONIC ISCHEMIC GLOMERULONEPHROPATHY; CHRONIC KIDNEY FAILURE; CINCA SYNDROME; DACTYLITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GLOMERULOPATHY; HEMODIALYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERCOAGULABILITY; IMMUNE COMPLEX NEPHRITIS; IMMUNE COMPLEX RENAL VASCULITIS; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY ISCHEMIA; LOADING DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEDICAL LITERATURE; NEPHRITIS; PANCYTOPENIA; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; THROMBOCYTOPENIA; VASCULAR DISEASE; VASCULITIS;

ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649324986     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1485-4     Document Type: Article

References (21)

1. PV Voulgari AI Venetsanopoulou EK Epagelis Y Alamanos I Takalou AA Drosos 2007 Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience Ann Rheum Dis 66 270 271 10.1136/ard.2006.058735 17068063 (Pubitemid 46226069)
2. PV Voulgari AI Venetsanopoulou SA Exarchou Y Alamanos N Tsifetaki AA Drosos 2008 Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term study Semin Arthritis Rheum 37 293 298 1:CAS:528:DC%2BD1cXjs1Kjtrc%3D 10.1016/j.semarthrit.2007.07.003 17888499 (Pubitemid 351389480)
3. M Dougados S van der Linden R Juhlin B Huitfeldt B Amor A Calin 1991 The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy Arthritis Rheum 34 1218 27 1:STN:280:DyaK38%2FivFSqsA%3D%3D 10.1002/art.1780341003 1930310
4. FX Thierry I Vernier JM Dueymes H Roche P Canal F Meeus, et al. 1989 Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removal Nephron 51 416 417 1:STN:280:DyaL1M7ktlyltw%3D%3D 10.1159/000185335 2918955
5. SM Wall MJ Johansen DA Molony TD DuBose Jr N Jaffe T Madden 1996 Effective clearance of methotrexate using high-flux hemodialysis membranes Am J Kidney Dis 28 846 854 1:CAS:528:DyaK2sXitlyqug%3D%3D 10.1016/S0272-6386(96) 90384-4 8957036
6. S Gutierrez-Ureña JF Molina CO García ML Cuéllar LR Espinoza 1996 Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis Arthritis Rheum 39 272 276 10.1002/art.1780390214 8849378 (Pubitemid 26065267)
7. MH Ellman D Ginsberg 1990 Low-dose methotrexate and severe neutropenia in patients undergoing renal dialysis Arthritis Rheum 33 1060 1061 1:STN:280:DyaK3czhsV2rug%3D%3D 10.1002/art.1780330724 2369423 (Pubitemid 20226364)
8. WW Chatham SL Morgan GS Alarcón 2000 Renal failure: a risk factor for methotrexate toxicity Arthritis Rheum 43 1185 1186 1:STN:280: DC%2BD3c3nsFaktA%3D%3D 10.1002/1529-0131(200005)43:5<1185::AID-ANR30>3.0. CO;2-V 10817575 (Pubitemid 30368200)
9. GR Aronoff 2005 Dose adjustment in renal impairment: response from drug prescribing in renal failure BMJ 331 293 294 10.1136/bmj.331.7511.293-a 16052026
10. J Vega M de L Rodriguez A Vasquez C Torres 2004 Bone marrow aplasia during hemodialysis successfully treated with cyclosporine. Report of one case Rev Med Chil 132 989 994 15478302
11. WS Chen AH Young HP Wang DF Huang 2009 Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A Rheumatol Int 29 821 824 1:CAS:528:DC%2BD1MXhsVeis7fM 10.1007/s00296-008-0826-y 19156422
12. I Nestorov 2005 Clinical pharmacokinetics of tumor necrosis factor antagonists J Rheumatol 74 suppl 13 18 1:CAS:528:DC%2BD2MXivVynsrs%3D
13. MB Stokes K Foster GS Markowitz F Ebrahimi W Hines D Kaufman, et al. 2005 Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis Nephrol Dial Transplant 20 1400 1406 1:CAS:528:DC%2BD2MXpt1Cjs7g%3D 10.1093/ndt/gfh832 15840673 (Pubitemid 41430613)
14. AA den Broeder KJ Assmann PL van Riel JF Wetzels 2003 Nephrotic syndrome as a complication of anti-TNF alpha in a patient with rheumatoid arthritis Neth J Med 61 137 141
15. G Chin G Luxton JM Harvey 2005 Infliximab and nephrotic syndrome Nephrol Dial Transplant 20 2824 2826 1:CAS:528:DC%2BD2MXht1entLvI 10.1093/ndt/gfi180 16204273 (Pubitemid 41672286)
16. R Singh R Cuchacovich W Huang LR Espinoza 2002 Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis J Rheumatol 29 636 637 11908584
17. M Hammoudeh 2006 Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis Rheumatology (Oxford) 45 357 359 1:STN:280: DC%2BD287gt1Smug%3D%3D 10.1093/rheumatology/kei264 (Pubitemid 43372859)
18. AM Yee MB Pochapin 2001 Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy Ann Intern Med 135 27 31 1:STN:280:DC%2BD3MvgsVWjug%3D%3D 11434729
19. AJ Hueber A Tunc G Schett B Manger 2007 Anti-tumour necrosis factor alpha therapy in patients with impaired renal function Ann Rheum Dis 66 981 982 10.1136/ard.2006.069211 17337474
20. JE Gottenberg F Merle-Vincent F Bentaberry Y Allanore F Berenbaum B Fautrel, et al. 2003 Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a follow up report of tolerability and efficacy Arthritis Rheum 48 2019 2024 1:CAS:528:DC%2BD3sXmtFartbs%3D 10.1002/art.11163 12847696 (Pubitemid 36828697)
21. V Ortiz-Santamaria M Valls-Roc M Sanmartí A Olive 2003 Anti-TNF treatment in secondary amyloidosis Rheumatology (Oxford) 42 1425 1426 1:STN:280:DC%2BD3srgtF2htg%3D%3D 10.1093/rheumatology/keg361 (Pubitemid 37407044)